Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Precision Promise Platform Trial for Metastatic Pancreatic Cancer

Precision Promise Platform Trial for Metastatic Pancreatic Cancer

99 years or below
All genders
Precision Promise is a multi-center, seamless Phase 2/3 platform trial designed to evaluate multiple regimens in metastatic pancreatic cancer. The goal of the platform is to find effective therapies for pancreatic cancer. The platform will rapidly and efficiently test multiple novel drugs and combinations compared to standard of care therapy …
Learn More
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA)

Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA)

18 years - 99 years
All genders
Phase 3
Interventional
Randomized, multicenter, open-label, Phase 3 registration study designed to evaluate the safety and efficacy of milademetan compared to trabectedin in patients with unresectable or metastatic DD liposarcoma that progressed on 1 or more prior systemic therapies.
Learn More
A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

40 years - 90 years
All genders
Interventional
The purpose of this study is to evaluate the safety and efficacy of CNTX-6970. The target population is adults between 40 - 90 years old who have moderate to severe knee pain related to OA. The study drug is being compared to Celebrex, an FDA approved drug used to treat …
Learn More
Fixed-Dose Trial in Early Parkinson's Disease (PD) (TEMPO-1)

Fixed-Dose Trial in Early Parkinson's Disease (PD) (TEMPO-1)

40 years - 80 years
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics of 2 fixed doses of tavapadon and placebo in participants with early Parkinson's Disease
Learn More
Treatment of Moderate to Severely Active Systemic Lupus Erythematosus

Treatment of Moderate to Severely Active Systemic Lupus Erythematosus

18 years - 80 years
All genders
Phase 2
A Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus. The study duration will be 48 weeks, with a safety follow-up through week 56.
Learn More

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis

18 years - 80 years
All genders
to evaluate how effective dupilumab an injectable medication is and how safe it is in reducing the signs and symptoms in patients diagnosed with prurigo nodularis. Procedures include Physical exam, Medical History, Vital signs, Electrocardiogram, Blood and Urine samples, Tuberculosis assessment and subject questionnaires.
Learn More
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

18 years - 99 years
All genders
This is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Patients with Resectable Gastric and Gastroesophageal Cancer (GC/GEJC) (MATTERHORN).
Learn More
Upregulating action semantics to facilitate naming in aphasia

Upregulating action semantics to facilitate naming in aphasia

18 years - 99 years
All genders
Phase 1
The goal of this research is to improve the likelihood of aphasia treatment success by activating brain networks that can compensate for language impairment. We will use non-invasive brain stimulation and gesture-priming paradigms to encourage activation of action knowledge (semantics), which we predict will in turn boost verb retrieval. We …
Learn More
FLowRetriever for Acute Massive Pulmonary Embolism

FLowRetriever for Acute Massive Pulmonary Embolism

18 years - 99 years
All genders
Observational
To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism
Learn More
Visceral adipose tissue and frailty in idiopathic pulmonary fibrosis

Visceral adipose tissue and frailty in idiopathic pulmonary fibrosis

18 years - 99 years
All genders
The research study is being conducted to better understand how fat and muscle are related to disability and health-related quality of life in people with idiopathic pulmonary fibrosis.
Learn More
471 - 480 of 1243